From: Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
2005–2009 (n = 6317) | 2010–2014 (n = 7960) | p-value | |
---|---|---|---|
Early stagea | 81.5 | 86.3 | <.0001 |
Serous carcinoma | 77.7 | 84.1 | <.0001 |
Mucinous carcinoma | 87.6 | 88.6 | 0.379 |
Endometrioid carcinoma | 88.5 | 93.6 | 0.047 |
Clear cell carcinoma | 86.4 | 87.4 | 0.673 |
Distant stage | 38.7 | 43.9 | <.0001 |
Serous carcinoma | 44.1 | 49.5 | <.0001 |
Mucinous carcinoma | 30.2 | 31.5 | 0.247 |
Endometrioid carcinoma | 50.3 | 60.1 | 0.752 |
Clear cell carcinoma | 38.0 | 22.5 | 0.012 |